GlassScriptPhysician profile
Chuying Luo
NPI 1669451274
$3,222.79
in general payments reported to CMS, 2019-2025
17 companies · $420 in 2025
The $420 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2020: $112 · 2021: $429 · 2022: $909 · 2023: $780 · 2024: $378 · 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,578.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,577.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $668.72 | 2020-2025 | Bimzelx, Cimzia |
| Abbvie INC. | $520.81 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $511.15 | 2019-2025 | Absorica Ld, Winlevi, Ilumya |
| Janssen Biotech, INC. | $380.81 | 2021-2025 | Tremfya, Simponi, Simponi Aria |
| Novartis Pharmaceuticals Corporation | $276.47 | 2019-2025 | |
| Novo Nordisk INC | $237.19 | 2022 | |
| Helsinn Therapeutics (U.S.), INC. | $157.25 | 2019-2025 | Valchlor |
| Lilly USA, LLC | $140.86 | 2022-2024 | Taltz, Olumiant, Ebglyss |
| Incyte Corporation | $86.65 | 2021-2022 | |
| Leo Pharma INC. | $64.02 | 2019-2025 | Anzupgo |
| Biofrontera INC. | $53.50 | 2021 | |
| Kyowa Kirin, INC. | $37.05 | 2022-2024 | Poteligeo |
| Stemline Therapeutics INC. | $21.47 | 2019 | |
| Misonix INC | $19.42 | 2021 | |
| Bioventus LLC | $17.98 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.18 | 2025 | Spevigo |
| Genzyme Corporation | $12.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chuying Luo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.